Cardiol Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Cardiol Therapeutics Current Ratio Growth & History (CRDL)
Cardiol Therapeutics's current ratio was 4.16 for fiscal 2025.
View full Cardiol Therapeutics company overviewCardiol Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.16 | −0.36 | −8.01% |
| 2024 | 2024-12-31 | 4.52 | 0.16 | +3.66% |
| 2023 | 2023-12-31 | 4.36 | −1.91 | −30.45% |
| 2022 | 2022-12-31 | 6.27 | −1.27 | −16.83% |
| 2021 | 2021-12-31 | 7.53 | 1.60 | +26.92% |
| 2020 | 2020-12-31 | 5.94 | — | — |
Cardiol Therapeutics quarterly current ratio
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.55 | 3.09 | +125.30% |
| Q1 2026 | 2026-03-31 | 4.39 | 1.13 | +34.56% |
| Q4 2025 | 2025-12-31 | 4.16 | −0.36 | −8.01% |
| Q3 2025 | 2025-09-30 | 3.89 | — | — |
| Q2 2025 | 2025-06-30 | 2.46 | — | — |
| Q1 2025 | 2025-03-31 | 3.26 | — | — |
| Q4 2024 | 2024-12-31 | 4.52 | 0.16 | +3.66% |
| Q4 2023 | 2023-12-31 | 4.36 | −1.91 | −30.45% |
| Q4 2022 | 2022-12-31 | 6.27 | −1.27 | −16.83% |
| Q4 2021 | 2021-12-31 | 7.53 | 1.60 | +26.92% |
| Q4 2020 | 2020-12-31 | 5.94 | — | — |
Cardiol Therapeutics current ratio trends
Over the last five fiscal years, Cardiol Therapeutics's current ratio decreased from 5.94 to 4.16, a change of −1.78. The latest reported quarter, Q2 2026, shows 5.55.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardiol Therapeutics source filings ↗